In a new report, global experts outline key considerations to address persistent SARS-CoV-2; provide a roadmap to test critical new long COVID therapies
MEDFORD, Mass., Feb. 11, 2025 /PRNewswire/ — Long COVID, a debilitating condition following SARS-CoV-2 infection, continues to disable tens of millions of people globally, yet no approved treatments exist.
…